An Ultrasound‐Triggered STING Pathway Nanoagonist for Enhanced Chemotherapy‐Induced Immunogenic Cell Death
Small · 2024-06 · 20 (26)
DOI: 10.1002/smll.202309850 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, online erschienen am 15.01.2024. Verfasst von Ye Tian und 4 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Center and Institute of Translational Medicine, Faculty of Health Sciences, University of Macau, Taipa, Macau SAR, 999078, China. Hauptthemen laut MEDLINE: Doxorubicin, Immunogenic Cell Death, Zinc Oxide, Nanoparticles. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Faculty of Health Sciences, University of Macau, the Multi-Year Research Grant, Science and Technology Development Fund, Macau SAR.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Although chemotherapy has the potential to induce tumor immunotherapy via immunogenic cell death (ICD) effects, how to control the intensity of the immune responses still deserves further exploration. Herein, a controllable ultrasound (US)‐triggered chemo‐immunotherapy nanoagonist is successfully synthesized by utilizing the pH and reactive oxygen species (ROS) dual‐responsive PEG‐polyphenol to assemble sonosensitizer zinc oxide (ZnO) and doxorubicin (DOX). The PZnO@DOX nanoparticles have an intelligent disassembly to release DOX and zinc ions in acidic pH conditions. Notably, US irradiation generates ROS by sonodynamic therapy and accelerates the drug release process. Interestingly, after the PZnO@DOX+US treatment, the injured cells release double‐stranded DNA (dsDNA) from the nucleus and mitochondria into the cytosol. Subsequently, both the dsDNA and zinc ions bind with cyclic GMP‐AMP synthase and activate the stimulator of interferon genes (STING) pathway, resulting in the dendritic cell maturation, ultimately promoting DOX‐induced ICD effects and antigen‐specific T cell immunity. Therefore, chemotherapy‐induced immune responses can be modulated by non‐invasive control of US.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cancer Center and Institute of Translational Medicine, Faculty of Health Sciences, University of Macau, Taipa, Macau SAR, 999078, China.
- MoE Frontiers Science Center for Precision Oncology, University of Macau, Taipa, Macau SAR, 999078, China.
- State Key Lab of Metal Matrix Composites, School of Materials Science and Engineering, Shanghai Jiaotong University, Dongchuan Road 800, Shanghai, 200240, China.
ORCID-Profile: Yunlu Dai
Förderung
- National Natural Science Foundation of China
- Faculty of Health Sciences, University of Macau, the Multi-Year Research Grant
- Science and Technology Development Fund, Macau SAR
- Dr. Stanley Ho Medical Development Foundation
- Ministry of Education Frontiers Science Centre for Precision Oncology, University of Macau
- Research Services and Knowledge Transfer Office, University of Macau
Zitieren
APA
Tian, Y., Tian, H., Li, B., Feng, C., & Dai, Y. (2024). An Ultrasound‐Triggered STING Pathway Nanoagonist for Enhanced Chemotherapy‐Induced Immunogenic Cell Death. Small, 20(26). https://doi.org/10.1002/smll.202309850
Vancouver
Tian Y, Tian H, Li B, Feng C, Dai Y. An Ultrasound‐Triggered STING Pathway Nanoagonist for Enhanced Chemotherapy‐Induced Immunogenic Cell Death. Small. 2024;20(26). doi:10.1002/smll.202309850
BibTeX
@article{Tian2024,
author = {Tian, Ye and Tian, Hao and Li, Bei and Feng, Chuanliang and Dai, Yunlu},
title = {An Ultrasound‐Triggered STING Pathway Nanoagonist for Enhanced Chemotherapy‐Induced Immunogenic Cell Death},
journal = {Small},
year = {2024},
volume = {20},
number = {26},
doi = {10.1002/smll.202309850}
}
EUVIMED